Clinical Trials Browser

NIH × Brain Neoplasms × Imatinib Mesylate × Clear all

NCT00045734 2017-05-15

Imatinib Mesylate in Treating Patients With Recurrent Meningioma

Phase 2 Completed

23 enrolled 9 charts

Brain Neoplasms, Meningioma

NCT00904735 2013-08-12

Hydroxyurea With or Without Imatinib Mesylate in Treating Patients With Recurrent or Progressive Meningioma

Phase 2 Unknown

Brain Neoplasms, Meningioma, Central Nervous System Neoplasms